David Colleran - 09 Mar 2023 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: EVP, General Counsel, Corp Sec
Signature: /s/ David Colleran
Issuer symbol: ANIK
Transactions as of: 09 Mar 2023
Net transactions value: -$29,090
Form type: 4
Filing time: 10 Mar 2023, 15:51:39 UTC
Previous filing: 07 Mar 2023
Next filing: 14 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Options Exercise	$0	+3,683	+30%	$0.000000	15,956	09 Mar 2023	Direct	F1
transaction	ANIK	Common Stock	Tax liability	$29,090	-1,081	-6.8%	$26.91	14,875	09 Mar 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIK	Restricted Stock Unit	Award	$0	+16,395		$0.000000	16,395	09 Mar 2023	Common Stock	16,395	$0.000000	Direct	F4
transaction	ANIK	Stock Option (Right to Buy)	Award	$0	+35,790		$0.000000	35,790	09 Mar 2023	Common Stock	35,790	$29.60	Direct	F5, F6
transaction	ANIK	Restricted Stock Unit	Options Exercise	$0	-3,683	-50%	$0.000000	3,682	09 Mar 2023	Common Stock	3,683	$0.000000	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
F2	Reflects an aggregate of 1,081 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023.
F3	Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
F4	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
F5	Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
F6	The premium priced stock options vest in three equal annual installments beginning on March 9, 2024.
F7	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.